Control of cell cycle progression in human mesothelioma cells treated withgamma interferon

Citation
C. Vivo et al., Control of cell cycle progression in human mesothelioma cells treated withgamma interferon, ONCOGENE, 20(9), 2001, pp. 1085-1093
Citations number
52
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ONCOGENE
ISSN journal
09509232 → ACNP
Volume
20
Issue
9
Year of publication
2001
Pages
1085 - 1093
Database
ISI
SICI code
0950-9232(20010301)20:9<1085:COCCPI>2.0.ZU;2-S
Abstract
Recombinant human interferon gamma (r-hu-IFN gamma) exerts both antitumoral activity in the early stages of human malignant mesothelioma and a cytosta tic effect in human mesothelioma (HM) cell lines in vitro. The antiprolifer ative effect of interferons (IFNs) reported in a variety of cells has been attributed to several mechanisms. In order to progress in the understanding of HM cell growth modulation by r-hu-IFN gamma, modifications of cell cycl e progression and expression of key cell cycle regulator proteins in respon se to r-hu-IFN gamma were examined. Nine HM cell lines were studied, includ ing one resistant to the antiproliferative effect of r-hu-IFN gamma. Except in the resistant cell line r-hu-IFN gamma produced an arrest in the G1 and G2-M phases of the cell cycle, associated with a reduction in both cyclin A and cyclin dependent kinase inhibitors (CDKIs) expression. Moreover cycli n B1/cdc2 activity was decreased. The present study provides the first evid ence of a GZ-arrest in r-hu-IFN gamma -treated HM cell lines and indicates that HM cell lines, despite their tumorigenic origin still support cell cyc le control. The cell cycle arrest induced by r-hu-IFN gamma seems to depend on cyclin regulation through p21(WAF1/C1P1)- and p27(KiP1)-independent mec hanisms and is not directly related to the induced DNA damage.